An in vitro study on the risk of non-allergic type-I like hypersensitivity to Momordica charantia

BMC Complementary and Alternative Medicine

Rahsan Ilikci Sagkan¹ 

[1] Transplantation Laboratory, Division of Immunology and Allergy Diseases, Gulhane Military Medical Academy, Ankara, Turkey

关键词: Basophil activation;    Allergy;    Momordica charantia;   

Others  :  1220872
DOI  :  10.1186/1472-6882-13-284

 received in 2013-07-11, accepted in 2013-10-24,  发布年份 2013

【 摘 要 】

Background

Momordica charantia (MC) is a tropical plant that is extensively used in folk medicine. However, the knowledge about side effects of this plant is relatively little according to knowledge about its therapeutic effects. The aim of this study is to reveal the effects of non-allergic type-I like hypersensitivity to MC by an experiment which was designed in vitro.

Methods

In the present study, the expression of CD63 and CD203c on peripheral blood basophils against different dilutions of MC extracts was measured using flow cytometry and compared with one another. In addition to this, intra-assay CV’s of testing extracts were calculated for precision on reproducibility of test results.

Results

It was observed that the fruit extract of MC at 1/100 and 1/1000 dilutions significantly increased active basophils compared to same extract at 1/10000 dilution.

Conclusions

In conclusion, Momordica charantia may elicit a non-allergic type-I like hypersensitivity reaction in especially susceptible individuals.

【 授权许可】

   
2013 Ilikci Sagkan; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Mahmood A, Raja GK, Mahmood T, Gulfraz M, Khanum A: Isolation and characterization of antimicrobial activity conferring component(s) from seeds of bitter gourd (Momordica charantia). J Med Plants Res 2012, 6(4):566-573.
• [2]Bano F, Akthar N, Naz H: Effect of the aqueous extract of Momordica charantia on body weight of rats. J Basic Appl Sci 2011, 7(1):1-5.
• [3]Joseph B, Jini D: Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac J Trop Dis 2013, 3(2):93-102.
• [4]Liu JQ, Chen JC, Wang CF, Qiu MH: New cucurbitane triterpenoids and steroidal glycoside from Momordica charantia. Molecules 2009, 14(12):4804-4813.
• [5]Bakare RI, Magbagbeola OA, Akinwande AI, Ebuehi OA: Effect of aqueous leaf extract of Momordica charantia on intestinal enzyme activities in diarrhoeagenic mice. Nig Q J Hosp Med 2010, 20(1):24-28.
• [6]Alam S, Asad M, Asdaq SM, Prasad VS: Antiulcer activity of methanolic extract of Momordica charantia L. in rats. J Ethnopharmacol 2009, 123(3):464-469.
• [7]Patil SA, Patil SB: Toxicological studies of Momordica charantia Linn. Seed extracts in male mice. Int J Morphol 2011, 29(4):1212-1218.
• [8]Kumar DS, Sharathnath KV, Yogeswaran P, Harani A, Sudhakar K, Sudha P, Banji D: A medicinal potency of Momordica charantia. IJPSR 2010, 1(2):95-100.
• [9]Cunnick JE, Sakamoto K, Chapes SK, Fortner GW, Takemoto DJ: Induction of tumor cytotoxic immune cells using a protein from the bitter melon (Momordica charantia). Cell Immunol 1990, 126(2):278-289.
• [10]Lee-Huang S, Huang PL, Bourinbaiar AS, Chen HC, Kung HF: Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc Natl Acad Sci USA 1995, 92(19):8818-8822.
• [11]Manabe M, Takenaka R, Nakasa T, Okinaka O: Induction of anti-inflammatory responses by dietary Momordica charantia L. (bitter gourd). Biosci Biotechnol Biochem 2003, 67(12):2512-2517.
• [12]Abuaf N, Rostane H, Rajoely B, Gaouar H, Autegarden JE, Leynadier F, Girot R: Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy 2008, 38:921-928.
• [13]Silva LG, Lee IS, Kinghorm DA: Special Problems with the extraction of Plants. In Edited by Cannell JPR. 1993, 329-363. [Methods in Biotechnology]
• [14]McCloud TG: High throughput extraction of plant, marine and fungal specimens for preservation of biologically active molecules. Molecules 2010, 15:4526-4563.
• [15]Lapornik B, Prosek M, Wondra AG: Comparison of extracts prepared from plant byproducts using different solvents and extraction time. J Food Eng 2005, 71:214-222.
• [16]Natural Medicines Comprehensive Database [online database]. 2013. Available at: http://naturaldatabase.therapeuticresearch.com webcite
• [17]Braun L, Cohen M: Bitter melon. In Herbs & Natural Supplements. 2nd edition. Marrickville: Elsevier; 2007:123-130.
• [18]Meng Y, Liu B, Lei N, Zheng J, He Q, Li D, Zhao X, Shen F: Alpha-momorcharin possessing high immunogenicity, immunotoxicity and hepatotoxicity in SD rats. J Ethnopharmacol 2012, 139(2):590-598.
• [19]Eken C, Ozbek K, Yildirim CK, Eray O: Severe uvular edema and nasal mucosal necrosis due to Ecbalium elaterium (squirting cucumber): an allergic reaction or direct toxic effect? Clin Toxicol (Phila) 2008, 46(3):257-258.
• [20]Satar S, Gokel Y, Toprak N, Sebe A: Life-threatening uvular angioedema caused by Ecbalium elaterium. Eur J Emerg Med 2001, 8(4):337-339.
• [21]Kloutsos G, Balatsouras DG, Kaberos AC, Kandiloros D, Ferekidis E, Economou C: Upper airway edema resulting from use of Ecballium elaterium. Laryngoscope 2001, 111(9):1652-1655.
• [22]Reindl J, Anliker MD, Karamloo F, Vieths S, Wüthrich B: Allergy caused by ingestion of zucchini (Cucurbita pepo): characterization of allergens and cross-reactivity to pollen and other foods. J Allergy Clin Immunol 2000, 106(2):379-385.
• [23]Asero R, Mistrello G, Roncarolo D, de Vries SC, Gautier MF, Ciurana CL, Verbeek E, Mohammadi T, Knul-Brettlova V, Akkerdaas JH, Bulder I, Aalberse RC, Van Ree R: Lipid transfer protein: a pan-allergen in plant-derived foods that is highly resistant to pepsin digestion. Int Arch Allergy Immunol 2000, 122(1):20-32.
• [24]Fritsch R, Ebner H, Kraft D, Ebner C: Food allergy to pumpkinseed–characterization of allergens. Allergy 1997, 52(3):335-337.